Products

ГОРОС21.РУ

ГОРОС21.РУ – российская химико-фармацевтическая компания. Более 25 лет продаем фармацевтические субстанции и более 20 лет производим ветеринарные препараты.

goros21.ru Industry Software / Life Sciences & Biotech

AI Benchmark
Desktop
Capture pending
Mobile
Monthly visits
<5K
Sep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Unlinked
No verified creators
Launched
16mo ago
2025-07-17 · Est.

Traffic

Monthly visitsData through Sep 2026 · Oct 2026 pending

Marketing moves

Launches, search & content, referrals, promotions

  • New product launchLaunch

    Jul 17, 2025 · 16mo agoWebsite

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct28%
  • Organic Search24%
  • Display Ads22%
  • Referrals11%
  • Other15%

Countries

  • Russia78%
  • Peru21%
  • Ukraine1%

Search

Domain authority —Domain registered 2025-07-17

KeywordMonthly volume
тетрагон570
гентамицин390
tilodox360
тіамулін для свиней230
морфлоксацин кошкам40

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-11-04

Key pages

Weekly snapshots
www.goros21.ru/ Snapshot 2026-11-05

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does ГОРОС21.РУ get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ГОРОС21.РУ and what platforms does it support?
ГОРОС21.РУ is catalogued under Life Sciences & Biotech: ГОРОС21.РУ – российская химико-фармацевтическая компания. Более 25 лет продаем фармацевтические субстанции и более 20 лет производим ветеринарные препараты.. Supported platforms: Web.

Related products in this category

Industry Software / Life Sciences & Biotech

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.